日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

From fibrotic mechanisms to clinical translation: the drug therapy revolution and delivery system breakthrough in proliferative vitreoretinopathy

从纤维化机制到临床转化:增生性玻璃体视网膜病变药物治疗的革命和递送系统突破

Chen, Zijian; Liu, Jiangying; Quan, Liao; Wu, Lingdan; Xu, Qihua

Luteolin mitigates proliferative vitreoretinopathy through inhibition of ERK1/2 signaling and epithelial-mesenchymal transition

木犀草素通过抑制ERK1/2信号通路和上皮-间质转化来减轻增生性玻璃体视网膜病变。

Wu, Lingdan; Chen, Meiling; Chai, Jinghua; Tang, Yujie; Xu, Qihua

Exploring the mechanism of baicalein on choroid melanoma based on network pharmacology, transcriptomics and experimental verification

基于网络药理学、转录组学和实验验证,探讨黄芩苷对脉络膜黑色素瘤的作用机制

Wu, Lili; Li, Yue; Gan, Jiancheng; Wang, Anan; Zhang, Boyuan; Yu, Jinhai; Xu, Qihua; Liao, Hongfei

Identification of potential ferroptosis-related biomarkers in proliferative vitreoretinopathy based on machine learning

基于机器学习的增生性玻璃体视网膜病变中潜在铁死亡相关生物标志物的识别

Liu, Jiangying; Zhang, Shengxiang; Wu, Lingdan; Xue, Yingchao; Liu, Boyu; Song, Hongyan; Xu, Qihua

Efficacy and safety of Toujie Quwen Granules in patients infected with SARS-CoV-2: A prospective cohort study of 156 cases

头治屈瘟颗粒治疗SARS-CoV-2感染患者的疗效和安全性:一项纳入156例患者的前瞻性队列研究

Xu, Qihua; Zhang, Xinyue; Huang, Sanqi; Li, Linghua; Li, Feng; Liu, Wei; Ling, Kunzhou; Guan, Jialong; Tan, Xinghua; Lin, Luping

The CD163 + tissue-infiltrating macrophages regulate ferroptosis in thyroid-associated ophthalmopathy orbital fibroblasts via the TGF-β/Smad2/3 signaling pathway.

CD163+组织浸润巨噬细胞通过TGF-β/Smad2/3信号通路调节甲状腺相关眼病眼眶成纤维细胞的铁死亡

Li Xuemei, Wang Siyi, Cao Hanwen, Xu Simin, Xiong Chao, Yu Jinhai, Chen Yunxiu, Ren Zhangjun, Li Min, Hu Ying, Gan Puying, Xu Qihua, Wang Yaohua, Liao Hongfei

Efficacy and safety analysis of endoscopic navigation-guided 3D printing technology combined with absorbable materials in the treatment of orbital blowout fractures

内镜导航引导3D打印技术联合可吸收材料治疗眼眶爆裂性骨折的疗效和安全性分析

Ren, Zhangjun; Yu, Jinhai; Sang, Zexi; Xiong, Chao; Gan, Puying; Jin, Qi; Xu, Qihua; Liao, Hongfei

ZNF384 mediates KRT23 to promote CRC process through the TGF-β/Smad signaling pathway.

ZNF384 介导 KRT23 通过 TGF-β/Smad 信号通路促进 CRC 进程

Liu Jianfeng, Li Yuanyuan, Liao Bingling, Xu Qihua, Zhou Ying, Zhang Huijun

Consensus on the Treatment of Severe Ocular Trauma and Silicone Oil-Dependent Eyes Using Foldable Capsular Vitreous Body

关于使用可折叠囊状玻璃体治疗严重眼外伤和硅油依赖型眼的共识

Yan, Hua; Lin, Xiaofeng; Wei, Wenbin; Xu, Gezhi; Kuhn, Ferenc; Hu, Yuntao; Sun, Dawei; Yu, Weihong; Jiang, Rui; Zhao, Peiquan; Huang, Yanming; Cai, Jinhong; Wu, Nan; Chen, Zhen; Jia, Jinchen; Liu, Shenwen; Song, Huping; Li, Jianqiao; Shi, Xiangyu; Deng, Aijun; Beden, Umit; Petrou, Petros; Overdam, Van; Skihirtladze, Shalva; Cisiecki, Slawomir; Karabas, Levent; Long, Chongde; Qiao, Lifeng; Zhao, Zhenquan; Ma, Jian; Ji, Sujuan; Zhang, Yanlai; Yuan, Gongqiang; Xu, Qihua; Xu, Xiangzhong; Tian, Xuemin; Zhang, Haokun; Chen, Siyue

Rational Design of PARP1/c-Met Dual Inhibitors for Overcoming PARP1 Inhibitor Resistance Induced by c-Met Overexpression

合理设计PARP1/c-Met双抑制剂以克服c-Met过表达引起的PARP1抑制剂耐药性

Zeren Sun, Lanjie Li, Bingxin Zhai, Mengxuan Hu, Lei Huang, Shihui Huang, Liu Ye, Xiangying Kong, Jie Xu, Jie Bai, Jingjie Yan, Qichen Zhou, Zheqi Hu, Yuchen Zhang, Yuhan Jiang, Yan Zhang, Zhou Qiao, Yi Zou, Yungen Xu, Qihua Zhu